Intestinal Lymphatic Delivery of Praziquantel by Solid Lipid Nanoparticles: Formulation Design,In VitroandIn VivoStudies

about

Enhanced and Extended Anti-Hypertensive Effect of VP5 Nanoparticles.Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative.Screening of process variables using Plackett-Burman design in the fabrication of gedunin-loaded liposomes.

P2860

Q38789463-0566047F-7B10-4B28-827B-E904AED7F846 Q42366841-C2AFE49F-CF1F-4BBA-A6CA-4C8849AA0280 Q54446371-D2DE7FB8-DECB-43D8-B5D9-F7F645CA0097

P2860

Intestinal Lymphatic Delivery of Praziquantel by Solid Lipid Nanoparticles: Formulation Design,In VitroandIn VivoStudies

Item

http://www.wikidata.org/entity/Q59060853

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2014

@uk

name

Intestinal Lymphatic Delivery ...... sign,In VitroandIn VivoStudies

@en

Intestinal Lymphatic Delivery ...... sign,In VitroandIn VivoStudies

@nl

type

Item

label

Intestinal Lymphatic Delivery ...... sign,In VitroandIn VivoStudies

@en

Intestinal Lymphatic Delivery ...... sign,In VitroandIn VivoStudies

@nl

prefLabel

Intestinal Lymphatic Delivery ...... sign,In VitroandIn VivoStudies

@en

Intestinal Lymphatic Delivery ...... sign,In VitroandIn VivoStudies

@nl

P1476

Intestinal Lymphatic Delivery ...... sign,In VitroandIn VivoStudies

@en

P2093

Amit Mishra

http://www.w3.org/2001/XMLSchema#string

Parameswara Rao Vuddanda

http://www.w3.org/2001/XMLSchema#string

Sanjay Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics

Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins.

The production and characteristics of solid lipid nanoparticles (SLNs).

Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.

Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.

Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles.

Solid lipid nanoparticles: production, characterization and applications.

Intestinal lymphatic drug transport: an update.

Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/351693

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

nanoparticle

Intestinal Lymphatic Delivery of Praziquantel by Solid Lipid Nanoparticles: Formulation Design,In VitroandIn VivoStudies

about

P2860

P2860

Intestinal Lymphatic Delivery of Praziquantel by Solid Lipid Nanoparticles: Formulation Design,In VitroandIn VivoStudies

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P921